NASDAQ:DOX Amdocs (DOX) Stock Price, News & Analysis $40.50 -1.78 (-4.21%) Closing price 11/19/2026 04:00 PM EasternExtended Trading$40.52 +0.02 (+0.06%) As of 11/19/2026 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Amdocs Stock (NASDAQ:DOX) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Amdocs alerts:Sign Up Key Stats Today's Range$40.46▼$42.5050-Day Range$40.50▼$63.5752-Week Range$39.96▼$84.95Volume1.49 million shsAverage Volume2.35 million shsMarket Capitalization$4.37 billionP/E Ratio8.67Dividend Yield5.63%Price Target$69.00Consensus RatingHold Company Overview Amdocs provides software and services to communications and media companies. Its offerings include business and operational support systems for billing, customer management, service delivery and network operations, as well as cloud and digital solutions that help clients modernize their businesses and improve customer experiences. Founded in 1982, Amdocs serves communications and media providers in markets around the world. The company is headquartered in the St. Louis, Missouri, area and is led by President and Chief Executive Officer Shuky Sheffer.AI Generated. May Contain Errors. Read More Amdocs Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks98th Percentile Overall ScoreDOX MarketRank™: 4.877380463075 of 5 starsAmdocs scored higher than 98% of companies evaluated by MarketBeat, and ranked 34th out of 574 stocks in the technology sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.8 / 5Analyst RatingHold Consensus RatingAmdocs has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 2 buy ratings, 3 hold ratings, and 2 sell ratings.Upside PotentialAmdocs has a consensus price target of $69.00, representing about 70.4% upside from its current price of $40.50.Amount of Analyst CoverageAmdocs has only been the subject of 4 research reports in the past 90 days.Read more about Amdocs' stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth4.47% Earnings GrowthEarnings for Amdocs are expected to grow by 4.47% in the coming year, from $5.82 to $6.08 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Amdocs is 8.67, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 24.27.Price to Earnings Ratio vs. SectorThe P/E ratio of Amdocs is 8.67, which means that it is trading at a less expensive P/E ratio than the Technology sector average P/E ratio of about 38.76.Price to Earnings Growth RatioAmdocs has a PEG Ratio of 1.38. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioAmdocs has a P/B Ratio of 1.31. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Amdocs' valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted8.97% of the float of Amdocs has been sold short.Short Interest Ratio / Days to CoverAmdocs has a short interest ratio ("days to cover") of 9.29.Change versus previous monthShort interest in Amdocs has recently decreased by 0.96%, indicating that investor sentiment is improving. Dividend5.0 / 5Dividend StrengthStrong Dividend LeadershipAmdocs is a leading dividend payer. It pays a dividend yield of 5.38%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthAmdocs has been increasing its dividend for 14 years.Dividend CoverageThe dividend payout ratio of Amdocs is 48.82%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Amdocs will have a dividend payout ratio of 37.50% next year. This indicates that Amdocs will be able to sustain or increase its dividend.Read more about Amdocs' dividend. News and Social Media4.2 / 5News Sentiment0.75 News SentimentAmdocs has a news sentiment score of 0.75. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.46 average news sentiment score of Technology companies.News Coverage This WeekMarketBeat has tracked 26 news articles for Amdocs this week, compared to 6 articles on an average week.Search Interest11 people have searched for DOX on MarketBeat in the last 30 days. This is an increase of 450% compared to the previous 30 days.MarketBeat Follows3 people have added Amdocs to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days. Company Ownership3.4 / 5Insider TradingSelling Shares Cluster Insider Buying5 insiders have purchased shares of Amdocs in the last three months. Multiple insiders buying is a strong bullish signal.Insider Buying vs. Insider SellingIn the past three months, Amdocs insiders have sold 165.19% more of their company's stock than they have bought. Specifically, they have bought $354,505.00 in company stock and sold $940,113.00 in company stock.Percentage Held by Insiders15.40% of the stock of Amdocs is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions92.02% of the stock of Amdocs is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Amdocs' insider trading history. Receive DOX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Amdocs and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. DOX Stock News HeadlinesAmdocs Investor News: If You Have Suffered Losses in Amdocs Limited (NASDAQ: DOX), You Are Encouraged to Contact The Rosen Law Firm About Your RightsNovember 19 at 2:31 PM | globenewswire.comHAGENS BERMAN, NATIONAL SECURITIES LAW FIRM, Investigating Amdocs Limited (NASDAQ: DOX) Following Escalating T-Mobile Contract Dispute and Stock CollapseNovember 19 at 12:05 PM | prnewswire.comYour $7 scanner is waitingThe Instant Scanner is $7 in Bill Poulos's Black Friday sale. Every night it delivers a list showing which stock, what price, and when to exit. The list reads the same whether you've traded for twenty years or twenty days, and it doesn't depend on account size. If it's not for you, refund the $7 and still keep the scanner for the full year. One payment, no re-bills. | Profits Run (Ad)DOX Investigation: Amdocs is being Investigated for Securities Fraud Following T-Mobile Agreement Issues – Contact BFA Law if You Lost MoneyNovember 18 at 6:36 AM | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amdocs Limited - DOXNovember 17 at 5:45 PM | globenewswire.comAmdocs (NASDAQ:DOX) Stock: Insider La Vega Rafael De Purchases 2,297 SharesNovember 17 at 4:37 AM | insidertrades.comAmdocs (NASDAQ:DOX) Insider Shimie Hortig Sells 1,733 Shares of Company StockNovember 15, 2026 | insidertrades.comAmdocs (NASDAQ:DOX) Director John Anthony Macdonald Acquires 1,000 Shares of StockNovember 13, 2026 | insidertrades.comSee More Headlines DOX Stock Analysis - Frequently Asked Questions How have DOX shares performed this year? Amdocs' stock was trading at $80.51 at the start of the year. Since then, DOX shares have decreased by 49.7% and is now trading at $40.50. How were Amdocs' earnings last quarter? Amdocs Limited (NASDAQ:DOX) posted its quarterly earnings results on Tuesday, November, 3rd. The technology company reported $1.98 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $1.98. The company's revenue was up 3.8% on a year-over-year basis. Read the conference call transcript. Does Amdocs have any subsidiaries? The following companies are subsidiaries of Amdocs: Sourced Group, Openet, Telecom Technology Services, Vubiquity, Brite:Bill, Pontis, Vindicia, and more. Who are Amdocs' major shareholders? Amdocs' top institutional shareholders include Pzena Investment Management LLC (13.39%), Beutel Goodman & Co Ltd. (4.00%), First Trust Advisors LP (1.52%) and State Street Corp (1.21%). Insiders that own company stock include Eliahu Meir Gelman, Shimie Hortig, La Vega Rafael De, John Anthony Macdonald and Veronique Morali. View institutional ownership trends. How do I buy shares of Amdocs? Shares of DOX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Amdocs own? Based on aggregate information from My MarketBeat watchlists, some other companies that Amdocs investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Tesla (TSLA), Qualcomm (QCOM), Intel (INTC), Micron Technology (MU) and Home Depot (HD). Company Calendar Record date for 10/30 Dividend9/30/2026Ex-Dividend for 10/30 Dividend9/30/2026Dividend Payable10/30/2026Last Earnings11/03/2026Today11/19/2026Next Earnings (Estimated)2/02/2027Fiscal Year End9/30/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (2w+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 For the last 2 weeks, DOX's financial health has been in the Red zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorTechnology Industry IT Services Sub-IndustryIT Consulting & Other Services Current SymbolNASDAQ:DOX CIK1062579 Webwww.amdocs.com Phone(314) 212-7000Fax1 314 212 7500Employees26,969Year Founded1982Price Target and Rating Average Price Target for Amdocs$69.00 High Price Target$92.00 Low Price Target$46.00 Potential Upside/Downside+70.4%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage7 Analysts Profitability EPS (Trailing Twelve Months)$4.67 Trailing P/E Ratio8.67 Forward P/E Ratio6.66 P/E Growth1.38Net Income$497.42 million Net Margins10.59% Pretax Margin13.54% Return on Equity20.81% Return on Assets11.05% Debt Debt-to-Equity Ratio0.23 Current Ratio0.94 Quick Ratio0.94 Sales & Book Value Annual Sales$4.70 billion Price / Sales0.93 Cash Flow$8.13 per share Price / Cash Flow4.98 Book Value$30.88 per share Price / Book1.31Miscellaneous Outstanding Shares107,950,000Free Float91,326,000Market Cap$4.37 billion OptionableOptionable Beta0.42 Social Links The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (NASDAQ:DOX) was last updated on 11/19/2026 by MarketBeat.com Staff. From Our PartnersYour $7 scanner is waitingThe Instant Scanner is $7 in Bill Poulos's Black Friday sale. Every night it delivers a list showing which sto...Profits Run | SponsoredWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredBeyond NVDA: The World’s Next #1 Company?This small-cap trades in an overlooked corner of the market, with a market cap more than 600X smaller than Nvi...Banyan Hill Publishing | SponsoredELON + YOU + DECEMBER 8THElon Musk's next big project may be the most ambitious move of his career, and all signs point to December 8th...Paradigm Press | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and th...Porter & Company | Sponsored432 miles southeast of Washington, DC…Spruce Pine, North Carolina, a town of just over 2,000 people, has supplied a material to every major chip mak...Wall Street Watchdogs | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amdocs Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Amdocs With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.